Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 02:00 save search
Metering Pumps Market to grow by USD 1.09 billion during 2022-2027 | Growing industrial acceptance of positive displacement pumps to drive growth- Technavio
Published: 2023-10-10 (Crawled : 02:00) - prnewswire.com
ATLCY | $14.1 -2.81% 17K
|
Manufacturing
|
| O: 4.2%
H: 0.0%
C: -0.58%
ATLKY | $16.19 -11.01% 1M
|
Manufacturing
|
| O: 2.79%
H: 1.98%
C: -0.07%
IR | $90.57 2.19% 0.0% 1.5M
|
Producer Manufacturing
|
| O: 0.08%
H: 1.75%
C: 0.84%
positive growing market
Tonix Pharmaceuticals Presents Positive Efficacy and Safety Data from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 5th International Congress on Controversies in Fibromyalgia
Published: 2023-03-30 (Crawled : 02:00) - globenewswire.com
TNXP | $0.1574 1.29% 1.27% 1.6M
|
Health Technology
|
| O: 7.32%
H: 1.51%
C: -2.38%
tnx-102 management fibromyalgia positive international pharmaceuticals study
AmeriCann Reports Four Consecutive Quarters of Positive Net Income
Published: 2023-02-16 (Crawled : 02:00) - americann.co
ACAN | $0.065 69.23% 5.1K
|
Professional, Scientific, and T...
|
| O: 13.68%
H: 0.0%
C: -7.14%
NNBR | $3.98 4.19% 4.02% 200K
|
Producer Manufacturing
|
| O: -0.91%
H: 3.21%
C: 2.29%
positive
Natural Grocers® Now Hiring Select Positions for New Store in McCall, ID
Published: 2022-12-02 (Crawled : 02:00) - prnewswire.com
NGVC | $16.04 -1.05% -0.19% 46K
|
Retail Trade
|
| O: -1.08%
H: 2.59%
C: 0.4%
grocers store
Energy Fuels Announces 2021 Results, Including Net Profits, Strong Cash Position, and Market-Leading U.S. Uranium, Rare Earth and Vanadium Position
Published: 2022-03-16 (Crawled : 02:00) - prnewswire.com
UUUU | $5.24 -1.13% -0.19% 4.8M
|
Non-Energy Minerals
|
| O: 3.39%
H: 2.34%
C: -3.04%
pos rare energy results uranium positive
Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
Published: 2022-03-01 (Crawled : 02:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.44%
H: 2.1%
C: 0.88%
heart therapeutics cel lung cancer positive cancer designation
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2022-03-01 (Crawled : 02:00) - globenewswire.com
AQST | $4.265 -2.63% -2.7% 1.7M
|
Health Technology
|
| O: 2.51%
H: 6.29%
C: 0.7%
aqst-109 america therapeutics epinephrine phase 1 positive results topline immunology
Dimethyl Ether Market to grow at a CAGR of 15.49% from 2020 to 2025 | Positive Impact of DME on the Environment to Boost Market |17000+ Technavio Reports
Published: 2021-11-17 (Crawled : 02:00) - prnewswire.com
RYDAF | $33.69 -7.36% 2K
|
Energy Minerals
|
| O: -0.89%
H: 0.0%
C: -0.85%
positive
Positive Interim Results of CHOICE-01 Study Evaluating Coherus' and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
Published: 2021-09-14 (Crawled : 02:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.47%
H: 0.07%
C: -1.4%
CHRS | $2.19 0.46% 0.46% 810K
|
Health Technology
|
| O: 0.31%
H: 0.49%
C: -0.86%
treatment lung cancer positive results cancer conference
Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
Published: 2021-09-14 (Crawled : 02:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.47%
H: 0.07%
C: -1.4%
CHRS | $2.19 0.46% 0.46% 810K
|
Health Technology
|
| O: 0.31%
H: 0.49%
C: -0.86%
treatment lung cancer positive results cancer conference
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published: 2021-08-19 (Crawled : 02:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.92%
H: 2.37%
C: 1.48%
CHRS | $2.19 0.46% 0.46% 810K
|
Health Technology
|
| O: 1.27%
H: 8.73%
C: 1.47%
treatment lung cancer positive therapy results cancer phase 3 trial
Human Capital Management (HCM) Solutions Market | Position of Automatic Data Processing Inc., Ceridian HCM Holding Inc., and Infor to remain dominant during the forecast period
Published: 2021-08-11 (Crawled : 02:00) - prnewswire.com
SAP | News | $188.01 5.52% 0.13% 1.6M
|
Technology Services
|
| O: 0.48%
H: 0.12%
C: -0.83%
ACN | News S | $316.83 -0.19% 0.0% 2M
|
Technology Services
|
| O: 0.14%
H: 0.07%
C: -0.26%
positive
Payroll Outsourcing Services Market | Position of Accenture Plc, Automatic Data Processing Inc., Deloitte Touche Tohmatsu Ltd. to remain dominant during the forecast period
Published: 2021-08-11 (Crawled : 02:00) - prnewswire.com
HPQ | $27.67 -0.11% -0.03% 6M
|
Electronic Technology
|
| O: -0.03%
H: 2.22%
C: 1.28%
ACN | News S | $316.83 -0.19% 0.0% 2M
|
Technology Services
|
| O: 0.14%
H: 0.07%
C: -0.26%
positive
Over $ 2.5 Billion growth expected in Visual Effects (VFX) Market during 2020-2024 | Position of Deluxe Entertainment Services Group Inc., Digital Domain Holdings Ltd., Digital Idea Corp. to remain dominant during the forecast period
Published: 2021-08-11 (Crawled : 02:00) - prnewswire.com
ACN | News S | $316.83 -0.19% 0.0% 2M
|
Technology Services
|
| O: 0.14%
H: 0.07%
C: -0.26%
growth
Sorrento Reports Positive Initial Result in Dosing of First Enbrel-Non-Responding Rheumatoid Arthritis Patient With the Sofusa® Lymphatic Drug Delivery Device
Published: 2021-05-20 (Crawled : 02:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 1.43%
H: 4.24%
C: 1.98%
rheumatoid arthritis positive drug device drug delivery liver
Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
Published: 2020-12-17 (Crawled : 02:00) - globenewswire.com
ZLAB | $15.13 0.93% 0.93% 470K
|
Health Technology
|
| O: 4.86%
H: 0.57%
C: 0.22%
MGNX | $16.23 5.32% 5.05% 650K
|
Health Technology
|
| O: 11.44%
H: 2.33%
C: -10.52%
fda approval fda approval cancer breast cancer positive her2+ her2- her2
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.